U-Blot® Research Grade becotatugCat. No. WA2488$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade becotatugCat. No. WA2488
U-Blot® Research Grade BecotatugCat. No. WA2487
U-Blot® Research Grade BebtelovimabCat. No. WA2486
U-Blot® Research Grade BD0801Cat. No. WA2485
U-Blot® Research Grade BavituximabCat. No. WA2484
U-Blot® Research Grade BatoclimabCat. No. WA2483
U-Blot® Research Grade BatiraxceptCat. No. WA2482
U-Blot® Research Grade BasiliximabCat. No. WA2481
U-Blot® Research Grade BarzolvolimabCat. No. WA2480
U-Blot® Research Grade BarecetamabCat. No. WA2479
U-Blot® Research Grade BapotulimabCat. No. WA2478
U-Blot® Research Grade BapineuzumabCat. No. WA2477